HEADER TRANSFERASE/TRANSFERASE INHIBITOR 01-APR-17 5VCX TITLE CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN (UNTREATED) IN COMPLEX TITLE 2 WITH SARACATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2- COMPND 3 INHIBITORY KINASE; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 75-362; COMPND 6 SYNONYM: MYT1 KINASE; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PKMYT1, MYT1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)-RIPL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS KINASE DOMAIN, CELL CYCLE, TYROSINE- AND THREONINE-SPECIFIC KINASE, KEYWDS 2 MEMBRANE-ASSOCIATED PROTEIN KINASE, TRANSFERASE, INHIBITOR, KEYWDS 3 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.-Y.ZHU,E.SCHONBRUNN REVDAT 4 04-OCT-23 5VCX 1 REMARK REVDAT 3 11-DEC-19 5VCX 1 REMARK REVDAT 2 11-OCT-17 5VCX 1 JRNL REVDAT 1 23-AUG-17 5VCX 0 JRNL AUTH J.Y.ZHU,R.A.CUELLAR,N.BERNDT,H.E.LEE,S.H.OLESEN,M.P.MARTIN, JRNL AUTH 2 J.T.JENSEN,G.I.GEORG,E.SCHONBRUNN JRNL TITL STRUCTURAL BASIS OF WEE KINASES FUNCTIONALITY AND JRNL TITL 2 INACTIVATION BY DIVERSE SMALL MOLECULE INHIBITORS. JRNL REF J. MED. CHEM. V. 60 7863 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28792760 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00996 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.81 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 9718 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 486 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.8196 - 3.8935 0.98 3146 166 0.1728 0.2198 REMARK 3 2 3.8935 - 3.0907 1.00 3056 161 0.2140 0.2618 REMARK 3 3 3.0907 - 2.7000 1.00 3030 159 0.2645 0.3125 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.110 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2328 REMARK 3 ANGLE : 1.162 3149 REMARK 3 CHIRALITY : 0.032 326 REMARK 3 PLANARITY : 0.004 413 REMARK 3 DIHEDRAL : 16.616 898 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 75 THROUGH 227 ) REMARK 3 ORIGIN FOR THE GROUP (A): 27.6729 -1.0843 1.2436 REMARK 3 T TENSOR REMARK 3 T11: 0.3419 T22: 0.3659 REMARK 3 T33: 0.4216 T12: -0.0479 REMARK 3 T13: 0.0408 T23: 0.0450 REMARK 3 L TENSOR REMARK 3 L11: 1.8955 L22: 1.7751 REMARK 3 L33: 1.8146 L12: 0.2507 REMARK 3 L13: 0.8528 L23: 0.4031 REMARK 3 S TENSOR REMARK 3 S11: -0.1406 S12: 0.0446 S13: -0.0020 REMARK 3 S21: -0.1506 S22: 0.1618 S23: -0.3138 REMARK 3 S31: -0.1851 S32: 0.2240 S33: 0.0029 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 228 THROUGH 300 ) REMARK 3 ORIGIN FOR THE GROUP (A): 13.5736 -3.9069 -9.4178 REMARK 3 T TENSOR REMARK 3 T11: 0.4871 T22: 0.3670 REMARK 3 T33: 0.3605 T12: -0.0158 REMARK 3 T13: 0.0173 T23: 0.0387 REMARK 3 L TENSOR REMARK 3 L11: 0.9608 L22: 0.2265 REMARK 3 L33: 0.7971 L12: -0.1375 REMARK 3 L13: 0.8972 L23: -0.1178 REMARK 3 S TENSOR REMARK 3 S11: -0.2553 S12: 0.0780 S13: -0.1605 REMARK 3 S21: 0.0422 S22: 0.1867 S23: -0.1651 REMARK 3 S31: -0.2683 S32: 0.0356 S33: -0.0194 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 301 THROUGH 361 ) REMARK 3 ORIGIN FOR THE GROUP (A): 2.1594 2.8416 -15.5731 REMARK 3 T TENSOR REMARK 3 T11: 0.7021 T22: 0.4809 REMARK 3 T33: 0.4669 T12: 0.0325 REMARK 3 T13: -0.1155 T23: 0.0914 REMARK 3 L TENSOR REMARK 3 L11: 1.0381 L22: 0.1715 REMARK 3 L33: 1.3027 L12: 0.1781 REMARK 3 L13: -0.8694 L23: -0.1012 REMARK 3 S TENSOR REMARK 3 S11: -0.4621 S12: 0.3647 S13: 0.2736 REMARK 3 S21: 0.0985 S22: 0.3261 S23: 0.3146 REMARK 3 S31: -0.7824 S32: -0.5643 S33: -0.5648 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5VCX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-APR-17. REMARK 100 THE DEPOSITION ID IS D_1000227244. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : ROSENBAUM-ROCK DOUBLE-CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9718 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 43.814 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 5.655 REMARK 200 R MERGE (I) : 0.04700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 27.8100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.77 REMARK 200 R MERGE FOR SHELL (I) : 0.32800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.840 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5VCV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 6.9 MG/ML MYT1, 25 MM HEPES, 100 MM REMARK 280 SODIUM CHLORIDE, 0.5 MM DTT, 0.1 M CALCIUM CHLORIDE, 0.05 M TRIS REMARK 280 PH 8.5, 10 % PEG 4000, 1 MM SARACATINIB, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.24000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.26500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.71500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.26500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.24000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.71500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 52 REMARK 465 HIS A 53 REMARK 465 HIS A 54 REMARK 465 HIS A 55 REMARK 465 HIS A 56 REMARK 465 HIS A 57 REMARK 465 HIS A 58 REMARK 465 SER A 59 REMARK 465 SER A 60 REMARK 465 GLY A 61 REMARK 465 VAL A 62 REMARK 465 ASP A 63 REMARK 465 LEU A 64 REMARK 465 GLY A 65 REMARK 465 THR A 66 REMARK 465 GLU A 67 REMARK 465 ASN A 68 REMARK 465 LEU A 69 REMARK 465 TYR A 70 REMARK 465 PHE A 71 REMARK 465 GLN A 72 REMARK 465 SER A 73 REMARK 465 MET A 74 REMARK 465 PRO A 362 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 324 N - CA - C ANGL. DEV. = 18.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 232 -2.25 70.27 REMARK 500 ASP A 233 48.85 -146.18 REMARK 500 LEU A 241 107.09 -59.18 REMARK 500 ASP A 251 76.15 56.06 REMARK 500 PHE A 324 5.13 86.66 REMARK 500 VAL A 358 1.96 -68.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue H8H A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5VCV RELATED DB: PDB REMARK 900 RELATED ID: 5VCW RELATED DB: PDB REMARK 900 RELATED ID: 5VCY RELATED DB: PDB REMARK 900 RELATED ID: 5VCZ RELATED DB: PDB REMARK 900 RELATED ID: 5VD0 RELATED DB: PDB REMARK 900 RELATED ID: 5VD1 RELATED DB: PDB REMARK 900 RELATED ID: 5VD3 RELATED DB: PDB DBREF 5VCX A 75 362 UNP Q99640 PMYT1_HUMAN 75 362 SEQADV 5VCX MET A 52 UNP Q99640 INITIATING METHIONINE SEQADV 5VCX HIS A 53 UNP Q99640 EXPRESSION TAG SEQADV 5VCX HIS A 54 UNP Q99640 EXPRESSION TAG SEQADV 5VCX HIS A 55 UNP Q99640 EXPRESSION TAG SEQADV 5VCX HIS A 56 UNP Q99640 EXPRESSION TAG SEQADV 5VCX HIS A 57 UNP Q99640 EXPRESSION TAG SEQADV 5VCX HIS A 58 UNP Q99640 EXPRESSION TAG SEQADV 5VCX SER A 59 UNP Q99640 EXPRESSION TAG SEQADV 5VCX SER A 60 UNP Q99640 EXPRESSION TAG SEQADV 5VCX GLY A 61 UNP Q99640 EXPRESSION TAG SEQADV 5VCX VAL A 62 UNP Q99640 EXPRESSION TAG SEQADV 5VCX ASP A 63 UNP Q99640 EXPRESSION TAG SEQADV 5VCX LEU A 64 UNP Q99640 EXPRESSION TAG SEQADV 5VCX GLY A 65 UNP Q99640 EXPRESSION TAG SEQADV 5VCX THR A 66 UNP Q99640 EXPRESSION TAG SEQADV 5VCX GLU A 67 UNP Q99640 EXPRESSION TAG SEQADV 5VCX ASN A 68 UNP Q99640 EXPRESSION TAG SEQADV 5VCX LEU A 69 UNP Q99640 EXPRESSION TAG SEQADV 5VCX TYR A 70 UNP Q99640 EXPRESSION TAG SEQADV 5VCX PHE A 71 UNP Q99640 EXPRESSION TAG SEQADV 5VCX GLN A 72 UNP Q99640 EXPRESSION TAG SEQADV 5VCX SER A 73 UNP Q99640 EXPRESSION TAG SEQADV 5VCX MET A 74 UNP Q99640 EXPRESSION TAG SEQRES 1 A 311 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 311 GLY THR GLU ASN LEU TYR PHE GLN SER MET HIS GLN LEU SEQRES 3 A 311 GLN PRO ARG ARG VAL SER PHE ARG GLY GLU ALA SER GLU SEQRES 4 A 311 THR LEU GLN SER PRO GLY TYR ASP PRO SER ARG PRO GLU SEQRES 5 A 311 SER PHE PHE GLN GLN SER PHE GLN ARG LEU SER ARG LEU SEQRES 6 A 311 GLY HIS GLY SER TYR GLY GLU VAL PHE LYS VAL ARG SER SEQRES 7 A 311 LYS GLU ASP GLY ARG LEU TYR ALA VAL LYS ARG SER MET SEQRES 8 A 311 SER PRO PHE ARG GLY PRO LYS ASP ARG ALA ARG LYS LEU SEQRES 9 A 311 ALA GLU VAL GLY SER HIS GLU LYS VAL GLY GLN HIS PRO SEQRES 10 A 311 CYS CYS VAL ARG LEU GLU GLN ALA TRP GLU GLU GLY GLY SEQRES 11 A 311 ILE LEU TYR LEU GLN THR GLU LEU CYS GLY PRO SER LEU SEQRES 12 A 311 GLN GLN HIS CYS GLU ALA TRP GLY ALA SER LEU PRO GLU SEQRES 13 A 311 ALA GLN VAL TRP GLY TYR LEU ARG ASP THR LEU LEU ALA SEQRES 14 A 311 LEU ALA HIS LEU HIS SER GLN GLY LEU VAL HIS LEU ASP SEQRES 15 A 311 VAL LYS PRO ALA ASN ILE PHE LEU GLY PRO ARG GLY ARG SEQRES 16 A 311 CYS LYS LEU GLY ASP PHE GLY LEU LEU VAL GLU LEU GLY SEQRES 17 A 311 THR ALA GLY ALA GLY GLU VAL GLN GLU GLY ASP PRO ARG SEQRES 18 A 311 TYR MET ALA PRO GLU LEU LEU GLN GLY SER TYR GLY THR SEQRES 19 A 311 ALA ALA ASP VAL PHE SER LEU GLY LEU THR ILE LEU GLU SEQRES 20 A 311 VAL ALA CYS ASN MET GLU LEU PRO HIS GLY GLY GLU GLY SEQRES 21 A 311 TRP GLN GLN LEU ARG GLN GLY TYR LEU PRO PRO GLU PHE SEQRES 22 A 311 THR ALA GLY LEU SER SER GLU LEU ARG SER VAL LEU VAL SEQRES 23 A 311 MET MET LEU GLU PRO ASP PRO LYS LEU ARG ALA THR ALA SEQRES 24 A 311 GLU ALA LEU LEU ALA LEU PRO VAL LEU ARG GLN PRO HET H8H A 401 38 HET EDO A 402 4 HETNAM H8H N-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-7-[2-(4- HETNAM 2 H8H METHYLPIPERAZIN-1-YL)ETHOXY]-5-(TETRAHYDRO-2H-PYRAN-4- HETNAM 3 H8H YLOXY)QUINAZOLIN-4-AMINE HETNAM EDO 1,2-ETHANEDIOL HETSYN H8H SARACATINIB HETSYN EDO ETHYLENE GLYCOL FORMUL 2 H8H C27 H32 CL N5 O5 FORMUL 3 EDO C2 H6 O2 FORMUL 4 HOH *32(H2 O) HELIX 1 AA1 SER A 104 SER A 109 1 6 HELIX 2 AA2 GLY A 147 GLY A 165 1 19 HELIX 3 AA3 SER A 193 GLY A 202 1 10 HELIX 4 AA4 PRO A 206 SER A 226 1 21 HELIX 5 AA5 ASP A 270 MET A 274 5 5 HELIX 6 AA6 ALA A 275 GLY A 281 5 7 HELIX 7 AA7 THR A 285 ASN A 302 1 18 HELIX 8 AA8 GLY A 308 ARG A 316 1 9 HELIX 9 AA9 SER A 329 LEU A 340 1 12 HELIX 10 AB1 THR A 349 ALA A 355 1 7 SHEET 1 AA1 6 ARG A 80 ARG A 81 0 SHEET 2 AA1 6 LEU A 173 GLU A 179 -1 O GLU A 178 N ARG A 80 SHEET 3 AA1 6 ILE A 182 GLU A 188 -1 O TYR A 184 N TRP A 177 SHEET 4 AA1 6 LEU A 135 SER A 141 -1 N LYS A 139 O LEU A 185 SHEET 5 AA1 6 GLY A 122 SER A 129 -1 N PHE A 125 O VAL A 138 SHEET 6 AA1 6 PHE A 110 GLY A 119 -1 N LEU A 113 O LYS A 126 SHEET 1 AA2 2 LEU A 229 VAL A 230 0 SHEET 2 AA2 2 VAL A 256 GLU A 257 -1 O VAL A 256 N VAL A 230 SHEET 1 AA3 2 ILE A 239 GLY A 242 0 SHEET 2 AA3 2 ARG A 246 LEU A 249 -1 O LYS A 248 N PHE A 240 CISPEP 1 PRO A 243 ARG A 244 0 -9.17 CISPEP 2 ARG A 244 GLY A 245 0 -7.61 CISPEP 3 ALA A 261 GLY A 262 0 -4.42 SITE 1 AC1 13 LEU A 116 TYR A 121 VAL A 124 ALA A 137 SITE 2 AC1 13 LYS A 139 LEU A 185 THR A 187 GLU A 188 SITE 3 AC1 13 CYS A 190 GLY A 191 PHE A 240 ASP A 251 SITE 4 AC1 13 HOH A 523 SITE 1 AC2 3 LYS A 235 ASN A 238 ASP A 251 CRYST1 56.480 69.430 86.530 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017705 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014403 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011557 0.00000